This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Jan;1(1):1-8.

doi: 10.1007/BF03346764.

Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients

A Salvetti, L Poli, F Arzilli, L Sassano, R Pedrinelli, M Motolese

PMID: 226572
DOI: 10.1007/BF03346764

Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients

A Salvetti et al. J Endocrinol Invest. 1978 Jan.

. 1978 Jan;1(1):1-8.

doi: 10.1007/BF03346764.

Authors

A Salvetti, L Poli, F Arzilli, L Sassano, R Pedrinelli, M Motolese

PMID: 226572
DOI: 10.1007/BF03346764

No abstract available

PubMed Disclaimer

Similar articles

Effects of beta 1-selective and non-selective beta-blockade on blood pressure, plasma renin activity and plasma aldosterone in hypertensive patients.
van Herwaarden CL, Fennis JF, van 'T Laar A. van Herwaarden CL, et al. Neth J Med. 1979;22(1):17-22. Neth J Med. 1979. PMID: 368667 Clinical Trial. No abstract available.
Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1977 Nov;14(5):321-48. doi: 10.2165/00003495-197714050-00001. Drugs. 1977. PMID: 201441 Review.
Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S, Bernheim J, Podjarny E. Benchetrit S, et al. Isr Med Assoc J. 2002 Jan;4(1):17-20. Isr Med Assoc J. 2002. PMID: 11802302
[Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J. Cortés P, et al. Rev Med Chil. 2000 Sep;128(9):955-61. Rev Med Chil. 2000. PMID: 11349499 Spanish.
[Pathogenesis of arterial hypertension with a low renin activity in the blood plasma].
Shkhvatsabaia IK, Chikhladze NM, Ustinova SE. Shkhvatsabaia IK, et al. Kardiologiia. 1978 Nov;18(11):5-11. Kardiologiia. 1978. PMID: 364165 Review. Russian.

See all similar articles

Cited by

Plasma potassium and adrenergic system.
Massara F, Camanni F, Molinatti GM. Massara F, et al. J Endocrinol Invest. 1978 Jul;1(3):289. doi: 10.1007/BF03350397. J Endocrinol Invest. 1978. PMID: 41870 No abstract available.
Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
Radó JP. Radó JP. J Endocrinol Invest. 1979 Oct-Dec;2(4):401-6. doi: 10.1007/BF03349340. J Endocrinol Invest. 1979. PMID: 395185
Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.
Phillips PJ, Vedig AE, Jones PL, Chapman MG, Collins M, Edwards JB, Smeaton TC, Duncan BM. Phillips PJ, et al. Br J Clin Pharmacol. 1980 May;9(5):483-91. doi: 10.1111/j.1365-2125.1980.tb05844.x. Br J Clin Pharmacol. 1980. PMID: 6104976 Free PMC article. Clinical Trial.

References

1. Lancet. 1976 Jan 31;1(7953):221-3 - PubMed
1. J Nucl Biol Med. 1973 Oct-Dec;17(4):187-95 - PubMed
1. Am J Med Sci. 1952 Jan;223(1):65-74 - PubMed
1. Br Med J. 1976 Feb 14;1(6006):365-7 - PubMed
1. Br J Pharmacol. 1969 Jan;35(1):141-51 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer